|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits in banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities - held to maturity (fair value $199,071 at June 30, 2023 and $203,080 at December 31, 2022) | ||||||||||||||||||||
| Investment securities - available for sale (at fair value) | ||||||||||||||||||||
| Investment securities - held to maturity, net of allowance for credit losses of $45 at June 30, 2024 and December 31, 2023 (fair value $143,030 at June 30, 2024 and $184,415 at December 31, 2023) | ||||||||||||||||||||
| Investment securities - held to maturity, net of allowance for credit losses of $102 at June 30, 2026 and December 31, 2025 (fair value $146,368 at June 30, 2026 and $148,889 at December 31, 2025) | ||||||||||||||||||||
| Equity investments not held for trading with readily determinable fair values | ||||||||||||||||||||
| Restricted investment in bank stock, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Unearned fees | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Goodwill and other intangibles | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other repossessed assets | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Pension asset | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Trust receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Non-interest bearing deposits | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| SERP deferred compensation | ||||||||||||||||||||
| Allowance for credit losses on unfunded commitments | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Common Stock - par value $0.01 per share; Authorized 25,000,000 shares; issued and outstanding 6,453,836 shares at June 30, 2026 and 6,499,476 at December 31, 2025 | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
